Clinical trial
Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
NCT01019148 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
- Lead sponsor
- Stanford University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- November 10, 2009
- Completion date
- December 31, 2029
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.